Aurora Cannabis (ACB) Set to Release Earnings on Wednesday

Aurora Cannabis (NASDAQ:ACB) is anticipated to post its Q2 2027 results before the market opens on Wednesday, November 4th. Analysts expect the company to post earnings of ($0.03) per share and revenue of $50.68 million for the quarter. Individuals may visit the company’s upcoming Q2 2027 earnings overview page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 8:00 AM ET.

Aurora Cannabis (NASDAQ:ACB) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of ($0.13) by $0.17. The business had revenue of $47.62 million for the quarter, compared to analysts’ expectations of $47.45 million. On average, analysts expect Aurora Cannabis to post ($0.07) EPS for the current fiscal year and $0.06 EPS for the next fiscal year.

Aurora Cannabis Stock Performance

Shares of ACB opened at $4.15 on Wednesday. Aurora Cannabis has a fifty-two week low of $2.56 and a fifty-two week high of $6.36. The firm has a 50 day moving average price of $4.03 and a 200-day moving average price of $3.55.

Analyst Ratings Changes

A number of brokerages recently commented on ACB. Wall Street Zen upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Sunday, September 13th. BMO Capital Markets upgraded shares of Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. Zacks Research cut Aurora Cannabis from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Weiss Ratings raised Aurora Cannabis from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 2nd. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold”.

Aurora Cannabis Company Profile

Aurora Cannabis Inc is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces, distributes and sells cannabis and cannabis-derived products for medical and adult-use markets. Its shares trade on the Toronto Stock Exchange and the Nasdaq under the symbol ACB.

Aurora’s product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes and other cannabis extracts. The company markets products through brands such as Aurora, San Rafael ’71, Daily Special and CanniMed, with offerings varying by market and applicable regulations.

The company serves Canada’s regulated adult-use and medical cannabis markets and has expanded its medical cannabis business internationally.